Professional Documents
Culture Documents
PDF Centrifugal Separations in Biotechnology 2Nd Edition Wallace Woon Fong Leung Ebook Full Chapter
PDF Centrifugal Separations in Biotechnology 2Nd Edition Wallace Woon Fong Leung Ebook Full Chapter
PDF Centrifugal Separations in Biotechnology 2Nd Edition Wallace Woon Fong Leung Ebook Full Chapter
https://textbookfull.com/product/modern-industrial-microbiology-
and-biotechnology-2nd-edition-nduka-okafor/
https://textbookfull.com/product/beginning-power-apps-the-non-
developer-s-guide-to-building-business-applications-2nd-edition-
tim-leung/
https://textbookfull.com/product/beginning-power-apps-the-non-
developers-guide-to-building-business-mobile-applications-2nd-
edition-tim-leung/
https://textbookfull.com/product/an-introduction-to-
polysaccharide-biotechnology-2nd-edition-stephen-e-harding/
Environmental biotechnology : principles and
applications 2nd Edition Perry L. Mccarty
https://textbookfull.com/product/environmental-biotechnology-
principles-and-applications-2nd-edition-perry-l-mccarty/
https://textbookfull.com/product/membrane-based-separations-in-
metallurgy-principles-and-applications-1st-edition-lan-ying-
jiang/
https://textbookfull.com/product/transferring-information-
literacy-practices-billy-tak-hoi-leung/
https://textbookfull.com/product/wallace-at-bay-wallace-of-the-
secret-service-book-7-3rd-edition-wilson/
https://textbookfull.com/product/separation-processes-in-
biotechnology-first-edition-asenjo/
Centrifugal Separations in
Biotechnology
Centrifugal Separations in
Biotechnology
Second Edition
Notices
Knowledge and best practice in this field are constantly changing. As new research and
experience broaden our understanding, changes in research methods, professional practices,
or medical treatment may become necessary.
Practitioners and researchers must always rely on their own experience and knowledge in
evaluating and using any information, methods, compounds, or experiments described herein.
In using such information or methods they should be mindful of their own safety and the
safety of others, including parties for whom they have a professional responsibility.
To the fullest extent of the law, neither the Publisher nor the authors, contributors, or editors,
assume any liability for any injury and/or damage to persons or property as a matter of
products liability, negligence or otherwise, or from any use or operation of any methods,
products, instructions, or ideas contained in the material herein.
British Library Cataloguing-in-Publication Data
A catalogue record for this book is available from the British Library
Library of Congress Cataloging-in-Publication Data
A catalog record for this book is available from the Library of Congress
ISBN: 978-0-08-102634-2
1 Introduction 1
1.1 Introduction 1
1.1.1 Common Host Cells for Secreting Recombinant
Protein 6
1.1.2 Platform for Protein Expression 8
1.1.3 Extracellular Protein 9
1.1.4 Intracellular Protein—Liquid 9
1.1.5 Intracellular Protein—Inclusion Body 10
1.2 Centrifugal Separation and Filtration 12
1.2.1 Sedimenting Centrifuge 14
1.2.2 Filtering Centrifuges 15
1.3 Pros and Cons of Filtration Versus Centrifugation 16
1.4 Generic Flow Sheet for Biopharmaceutical Process 18
1.5 Other Centrifugal Separations 19
1.6 Inputs and Outputs of Centrifuge 19
1.7 Separation Metrics 20
1.7.1 Protein Yield 20
1.7.2 Centrate Suspended Solids 20
1.7.3 Throughput Rate 21
1.7.4 Cell Viability 21
1.8 Text Organization 22
1.9 Summary 23
References 23
Problems 25
v
vi CONTENTS
4 Disk Centrifuge 73
4.1 Lamella/Inclined Plate Settler 73
4.1.1 Inclined Plate Settler Principle 73
4.1.2 Complications in Inclined Plate Settler 74
CONTENTS vii
xvii
Preface to Second Edition (2019)
xix
xx PREFACE TO SECOND EDITION (2019)
xxiii
xxiv PREFACE TO FIRST EDITION (2007)
interested. Readers who are not interested in modeling can jump directly
to Chapter 13. The Le number provides a basis for the scale-up and per-
formance prediction covered in Chapter 13. Here, numerous examples
are used to demonstrate the versatility of the numerical simulator built on
the Le-approach to forecast performance in parallel with concurrent test-
ing, which is often limited for various reasons. Numerical simulation can
also be used to analyze laboratory, pilot, and production test results to
validate machine and process performance. Therefore numerical simula-
tion can be used for laboratory screening, pilot testing, clinical
manufacturing testing, full-scale production testing, and even for small-
scale testing in the laboratory to investigate alternatives and improve-
ments of the existing process under production. Membrane processes,
such as microfiltration, ultrafiltration, and diafiltration, are frequently
used in bioseparation. Lastly, Chapter 14 is devoted to combining two
separation processes: centrifugation and membrane separation. Two
examples, respectively, on centrifugal filter in spintube and large rotating
membrane systems are discussed. The general approach can be extended
to other rotating membrane geometry.
Centrifugation has been treated as a black box in the past, as the sub-
ject is quite complex and nonintuitive. The subject involves multiple dis-
ciplines, such as fluid dynamics, mechanics and vibration, design,
material science, rheology, chemical and process engineering, chemistry,
biology, and physics. I hope this text will fulfill the quest of knowledge
rendering centrifuge a lot more “transparent” to biologists, biotechnolo-
gists, chemists, physicists, scientists, researchers, and practicing engi-
neers. The more they know the better they can deploy, comfortably and
without reservation, centrifuge as handy process equipment.
Problems are listed at the end of each chapter in the text, and they
complement and supplement the contents in the chapter. They are also
meant to reinforce the concept for the readers through practices, chal-
lenging their thoughts and understanding on the topic. Apart from practi-
tioners and researchers, this book is written primarily for 4th year
university student in the 4-year undergraduate study and research gradu-
ates in their MS or PhD research program in university taking biosepara-
tion, bioprocessing, advanced unit-operation/process engineering, or
similar courses.
I am grateful to Stella, Jessica, Jeffrey, my mother, and my late father
for putting up with me while I was devoted to preparing this book. Both
my late father and my dear friend and mentor, the late Professor Ascher
H. Shapiro, demonstrated dedication and perseverance in their lives,
which inspired me all along, especially during the trying times when I
xxvi PREFACE TO FIRST EDITION (2007)
1.1 Introduction
Biotechnology has revolutionized our life in the 20th century [1]. Its
impact is only now being felt from engineering food [2 4], engineering
and delivering drugs [5,6], to engineering consumable products. Without
doubt it will continue to influence our daily lives for years to come. One
of the many successful examples is that drugs, such as monoclonal anti-
bodies (mAbs) and some basic drug substances (i.e., the building block
for various drugs), can now be manufactured and formulated from bior-
eaction. One of the commonly used methods in biotechnology is the
recombinant DNA technique [7 9]. A desired gene is isolated from one
organism, and this is inserted into a small piece of carrier DNA called a
vector. It is highly desirable that the recombined DNA (vector plus
gene) can propagate in a similar or unrelated host/recipient cell.
The mammalian cell, such as the Chinese Hamster Ovary cell, is a
popular host cell. Fig. 1.1 shows a schematic of an animal cell which is
very similar to that of a mammalian cell. A characteristic size of the
mammalian cell is about 10 20 µm. Unlike a plant cell, there is no cell
wall for animal and mammalian cells, so they rely on a plasma mem-
brane to keep the intracellular contents intact. High shear stress acting
on the cell can rupture the fragile membrane releasing the intracellular
material.
Yeast (see schematic in Fig. 1.2), in eukaryotic single-celled microor-
ganisms classified as a member of fungus kingdom, has been commonly
used as a host cell in the recombinant DNA process, the knowledge and
experience of which we have gained from the brewery industry. Unlike
a mammalian cell, the yeast cell has a strong cell wall. Yeast cells are
smaller than mammalian cells and are typically between 7 and 10 µm.
Some common yeast hosts include, Saccharomyces cerevisiae (referred
commonly as baker yeast) and Pichia pastoris.
Bacteria, such as Escherichia coli (hereafter abbreviated as E. coli)
and Bacillus subtilis, have been used as host cells for the recombinant
Figure 1.2 Yeast cell schematic showing both cell wall and membrane.
Introduction 3
therapeutics. For example, mAb has been a popular antibody made in the
laboratory used for cancer treatment where the antibody is designed to
attach as a label to their counterpart protein (antigen) on a specific cancer
cell so that immune cells can spot and attack the cancer cells. As an
example, the mAb known commercially as alemtuzumab drug (note all
mAb drugs have the last three alphabets labeled as “mab,” which distin-
guishes them being mAb-based drugs) can target at the antigen CD52
found on the cancer cells that causes chronic lymphocytic leukemia [12].
As antigens are discovered to be linked to more specific cancers, more
mAbs have also been developed for cancer treatment. Some mAbs work
better on certain cancers than others. mAb can also attach to the antigen
on breast cancer cells blocking the growth of breast cancer cells.
Cancer cells can “turn off the switch” of immune cells to avoid being
attacked by the immune system in our bodies. Inhibitors, or commonly
known as checkpoints, are mAb produced by the recombinant protein
process, that inhibit the protein secreted from the cancer cells in “fool-
ing” the immune cells, thereby allowing the immune cells to carry out
their normal functions. As an example, PD-1 is a protein on the immune
T-cells. The immune T-cells are normally in a switch-off condition
because PD-1 has been attached by their counterpart PD-L1, another
protein that both normal cells and cancer cells have. In other words,
they have been switched off. Some cancer cells have an abundant PD-
L1 that is used to attach to the PD-1 of the immune T-cells thereby
evading being attacked. On the other hand, mAb can target at either PD-
1 or PD-L1 and inhibit their binding, thereby allowing the immune cells
to attack the cancer cells. For example, pembrolizumab is a PD-1 inhibi-
tor that can treat skin melanoma, non-small-cell lung cancer, kidney can-
cer, bladder cancer, head and neck cancer, and Hodhkin lymphoma [12].
As another example, atezolizumab is a PD-L1 inhibitor that can treat
bladder cancer, non-small-cell lung cancer, and Merkel cell carcinoma
[12]. New inhibitors are being developed rapidly over time as more
knowledge is being gained on the specifics of different cancers and their
behavior. The examples mentioned in the forgoing are just a few under
the broad umbrella of immunotherapy for which mAb plays an impor-
tant role. The main objective of immunotherapy is to enable the immune
system of patients to recognize or target specific cancer cells and destroy
them [13]. In 2005 the total mAb therapeutics entering first-in-human
studies per year is 35, 16 out of which are for cancer treatment. In 2017
the total mAb therapeutics rose to 105, and nearly 80 were for cancer
treatment. Indeed, the antibody therapeutics entering clinical study and
being approved are in record numbers [14].
Introduction 5
Sub-Order 1. Pseudaxonia.
The axis in this sub-order consists of numerous spicules tightly
packed together, or cemented together by a substance which is
probably allied to horn in its chemical composition. This substance
may be considerable in amount, in which case it remains after
decalcification as a spongy, porous residue; or it may be so small in
amount, as in Corallium, that the axis appears to be composed of
solid carbonate of lime. The statement is usually made that the axis
is penetrated by nutritive canals in certain genera, but the evidence
upon which this is based is unsatisfactory and in some cases
unfounded. There can be no doubt, however, that in some genera
the axis is porous and in others it is not, and this forms a useful
character for the separation of genera.
Sub-Order 2. Axifera.
The axis in this sub-order may be horny, or horny with a core of
calcium carbonate, or composed of horn impregnated with calcium
carbonate, or of nodes of horn alternating with internodes of calcium
carbonate. It may be distinguished from the axis of the Pseudaxonia
by the fact that in no case have definite spicules been observed to
take part in its formation. It has been suggested that as the Axifera
represent a line of descent distinct from that of the Pseudaxonia they
should be placed in a separate order. Apart from the character of the
axis, however, the two sub-orders show so many affinities in their
general anatomy that it is better to regard the two lines of descent as
united within the Gorgonacean limit. It is very improbable that the
two groups sprang independently from a stoloniferous ancestor.
Fam. 1. Isidae.—This family includes all those Axifera in which the
axis is composed of alternate nodes of horn and internodes of
calcareous substance.
There can be little doubt of the close affinities of many of the genera
of this family with the Melitodidae among the Pseudaxonia. In both
the coenenchym is thin and the coelenteric cavities short. No
important differences have been observed between the structure of
the zooids of the two families, and now that we know that the
"nutritive canals" of Melitodes do not perforate the nodes there is no
important difference left between the coenosarcal canal systems.
The structure and method of calcification of the internodes of the two
families are very similar. The main difference between them is that
the nodes of the Isidae are purely horny, whereas in the Melitodidae
the horny substance of the nodes contains calcareous spicules.
Order V. Pennatulacea.
The Sea-pens form a very distinct order of the Alcyonaria. They are
the only Alcyonarians that are not strictly sedentary in habit, that are
capable of independent movement as a whole, and exhibit a bilateral
symmetry of the colony. No genera have yet been discovered that
can be regarded as connecting links between the Pennatulacea and
the other orders of the Alcyonaria. Their position, therefore, is an
isolated one, and their relationships obscure.
The peculiarities of the order are due to the great growth and
modification in structure of the first formed zooid of the colony. This
zooid (Oozooid, Hauptpolyp, or Axial zooid) increases greatly in
length, develops very thick fleshy walls, usually loses its tentacles,
digestive organs, and frequently its mouth, exhibits profound
modification of its system of mesenteries, and in other ways
becomes adapted to its function of supporting the whole colony.
Fig. 158.—Diagram of a Sea-pen. L, leaves composed of a row of autozooids; R,
rachis; St, stalk; T, anthocodia of the axial zooid, usually suppressed. (After
Jungersen.)
Fig. 160.—Renilla reniformis, a small specimen (34 mm.), showing the dorsal
side of the expanded rachis. A, autozooid; H, the mouth of the axial zooid;